Common Contracts
3 similar Exclusive License Agreement contracts by Quadrant Biosciences Inc
Exclusive License Agreement BetweenExclusive License Agreement • February 14th, 2020 • Quadrant Biosciences Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement (hereinafter, "Agreement") is made and is effective as of the date of the last signature below (hereinafter, "Effective Date") by and between The Research Foundation for The State University of New York ("SUNY"), on behalf of Upstate Medical University ("Upstate"), a non-profit educational corporation, organized and existing under the laws of the State of New York, having offices at 750 East Adams St., WH 1109C ,Syracuse, NY 13210 (hereinafter, "Foundation"), The Penn State Research Foundation having a principal place of business at Office of Technology Management, 113 Technology Center, University Park, PA 16802 (hereinafter referred to as "PSRF") (individually "Licensor", collectively "Licensors"), and Quadrant Biosciences Inc., a Delaware corporation, having a primary address at 505 Irving Ave., Suite 3100AB, Syracuse, NY 13210 (hereinafter, "Licensee", and together with Foundation and PSRF, the "Parties", and each individually a "Party").
Exclusive License Agreement BetweenExclusive License Agreement • February 14th, 2020 • Quadrant Biosciences Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement (hereinafter, "Agreement") is made and is effective as of the date of the last signature below (hereinafter, "Effective Date") by and between The Research Foundation for The State University of New York ("SUNY"), on behalf of Upstate Medical University ("Upstate"), a non-profit educational corporation, organized and existing under the laws of the State of New York, having offices at 750 East Adams St., WH 1109C ,Syracuse, NY 13210 (hereinafter, "Foundation"), The Penn State Research Foundation having a principal place of business at Office of Technology Management, 113 Technology Center, University Park, PA 16802 (hereinafter referred to as "PSRF") (individually "Licensor", collectively "Licensors"), and Quadrant Biosciences Inc., a Delaware corporation, having a primary address at 505 Irving Ave., Suite 3100AB, Syracuse, NY 13210 (hereinafter, "Licensee", and together with Foundation and PSRF, the "Parties", and each individually a "Party").
Exclusive License Agreement BetweenExclusive License Agreement • February 14th, 2020 • Quadrant Biosciences Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement (hereinafter, "Agreement") is made and is effective as of the date of the last signature below (hereinafter, "Effective Date") by and between The Research Foundation for The State University of New York ("SUNY"), on behalf of Upstate Medical University ("Upstate"), a non-profit educational corporation, organized and existing under the laws of the State of New York, having offices at 750 East Adams St., WH 1109C ,Syracuse, NY 13210 (hereinafter, "Foundation"), The Penn State Research Foundation having a principal place of business at Office of Technology Management, 113 Technology Center, University Park, PA 16802 (hereinafter referred to as "PSRF") (individually "Licensor", collectively "Licensors"), and Quadrant Biosciences Inc., a Delaware corporation, having a primary address at 505 Irving Ave., Suite 3100AB, Syracuse, NY 13210 (hereinafter, "Licensee", and together with Foundation and PSRF, the "Parties", and each individually a "Party").
